News

Published on 7 Dec 2021 on Benzinga

The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More Setbacks For...

Article preview image

Here's a roundup of top developments in the biotech space over the last 24 hours:

Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) announced positive top-line results from a pivotal Phase 3 study evaluating the efficacy and safety of trofinetide in 187 girls and young women ages 5-20 with Rett syndrome.

Read the rest of the article
NASDAQ.IDYA price evolution
NASDAQ.VIR price evolution
NASDAQ.IONS price evolution
NASDAQ.MGTX price evolution
NASDAQ.APTX price evolution
NASDAQ.DARE price evolution
NASDAQ.ACAD price evolution
NASDAQ.CYTK price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Ideaya Biosciences Inc. (IDYA): Among the NASDAQ Stocks with Biggest Upside...

We recently compiled a list of the 12 NASDAQ Stocks with Biggest Upside Potential According to...

Insider Monkey · via Yahoo Finance 22 Nov 2024
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Analysts Are Pretty Bullish On The Stock After Recent Results

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) shareholders are probably feeling a little disappointed, s...

Simply Wall St. via Yahoo Finance 23 Feb 2024
IDEAYA Biosciences Inc CEO Yujiro Hata Sells 99,372 Shares

On February 9, 2024, Yujiro Hata, the President and CEO of IDEAYA Biosciences Inc (NASDAQ:IDYA), ...

GuruFocus.com via Yahoo Finance 13 Feb 2024
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) is largely controlled by institutional shareholders who own...

Key Insights Institutions' substantial holdings in IDEAYA Biosciences implies that they have sign...

Simply Wall St. via Yahoo Finance 28 Jan 2024
IDEAYA Biosciences Inc President and CEO Yujiro Hata Sells 75,000 Shares

On January 16, 2024, President and CEO Yujiro Hata sold 75,000 shares of IDEAYA Biosciences Inc (...

GuruFocus.com via Yahoo Finance 21 Jan 2024
IDEAYA Biosciences, Inc. (IDYA) Moves 7.6% Higher: Will This Strength Last?

IDEAYA Biosciences, Inc. (IDYA) shares soared 7.6% in the last trading session to close at $39.74...

Zacks via Yahoo Finance 14 Jan 2024
Can IDEAYA Biosciences, Inc. (IDYA) Climb 25.48% to Reach the Level Wall Street Analysts Expect?

Shares of IDEAYA Biosciences, Inc. (IDYA) have gained 18.8% over the past four weeks to close the...

Zacks via Yahoo Finance 14 Nov 2023
Analysts' Revenue Estimates For IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Are Surging Higher

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) shareholders will have a reason to smile today, with the a...

Simply Wall St. via Yahoo Finance 9 Nov 2023
IDEAYA Biosciences, Inc. (IDYA) Reports Q3 Loss, Lags Revenue Estimates

IDEAYA Biosciences, Inc. (IDYA) came out with a quarterly loss of $0.46 per share versus the Zack...

Zacks via Yahoo Finance 7 Nov 2023
Why IDEAYA Biosciences Stock Is Falling During Wednesday's Session - IDEAYA Biosciences...

Ideaya Biosciences Inc IDYA shares are trading lower by 11.6% to $24.10 Wednesday morning after t...

Benzinga 25 Oct 2023

Copyright Statfolio @ 2024

Social Accounts